The Effectiveness of mRNA Vaccine Boosters for Laboratory-Confirmed COVID-19 During a Period of Predominance of the Omicron Variant of SARS-CoV-2
Susana Monge(Instituto de Salud Carlos III), Miguel A. Hernán(Harvard University), Aurora Limia(Universidad Rey Juan Carlos), Amparo Larrauri(Instituto de Salud Carlos III), Clara Mazagatos(Instituto de Salud Carlos III), María José Sierra(Ministerio de Salud Pública), Elisa Martín‐Merino(Pharmaceuticals and Medical Devices Agency), Carmen Olmedo, Ayelén Rojas‐Benedicto(Universidad Nacional de Educación a Distancia)
Cited by 4
Related Papers
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Observational Studies Analyzed Like Randomized Experiments
|Epidemiology|2008|814
Activated Injectable Vitamin D and Hemodialysis Survival
|Journal of the American Society of Nephrology|2005|784